- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07583615
Social Attention in ASD and TD Children
Dynamic Gaze Strategies in ASD Children During Social Interactions: An Eye-Tracking Investigation Under Intention-Congruent and -Incongruent Conditions
Studieoversikt
Status
Detaljert beskrivelse
Studietype
Registrering (Faktiske)
Kontakter og plasseringer
Studiesteder
-
-
Sichuan
-
Chengdu, Sichuan, Kina, 611731
- School of Foreign Languages, University of Electronic Science and Technology of China
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Barn
Tar imot friske frivillige
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion Criteria:
- For ASD group: confirmed clinical diagnosis of Autism Spectrum Disorder. For TD group: Typically developing children without any developmental or neurological disorders.
Both groups: Normal or corrected-to-normal vision, no color vision deficiencies, and legal guardian provided written informed consent.
Exclusion Criteria:
- Failure to meet the study's group-specific screening cutoffs on the Social Responsiveness Scale (SRS) and Social Communication Questionnaire (SCQ) Known genetic syndromes, significant hearing loss, or uncorrectable visual impairment
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Kohorter og intervensjoner
Gruppe / Kohort |
|---|
|
Autism Spectrum Disorder (ASD) Group
|
|
Typically Developing (TD) Group
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Percentage of Total Fixation Duration on Human Faces during Entire Video
Tidsramme: During the full 27-second video presentation
|
Percentage of total fixation duration on human faces was calculated as (total fixation duration on all face areas of interest / total fixation duration on the entire video) × 100.
Fixation was defined as gaze maintained within a 1° visual angle for a minimum of 100 ms.
This measure was compared between the ASD and TD groups.
|
During the full 27-second video presentation
|
|
Total Fixation Duration on Human Faces during Entire Video
Tidsramme: During the full 27-second video presentation
|
Total fixation duration (in milliseconds) on human faces, calculated as the sum of all fixation durations that fell within face areas of interest (AOIs).
This measure was compared between the ASD and TD groups.
|
During the full 27-second video presentation
|
|
Percentage of Total Fixation Duration on Human Faces During Phase 4 (Emotional Feedback) by Condition
Tidsramme: During seconds 22-27 of the video
|
Percentage of fixation duration on faces was calculated for the emotional feedback phase separately for Preference-congruent and Preference-incongruent trials.
The interaction between Group (ASD vs. TD) and Condition (Congruent vs. Incongruent) was examined.
Higher percentages indicate greater allocation of visual attention to faces during emotional feedback.
|
During seconds 22-27 of the video
|
|
Total Scanpath Length During Entire Video
Tidsramme: During the full 27-second video presentation
|
During the full 27-second video presentation
|
|
|
Number of Gaze Shifts Between Face and Object Areas of Interest
Tidsramme: During the full 27-second video presentation
|
The number of saccadic gaze shifts that cross between pre-defined face and object areas of interest (AOIs) was counted.
This was taken as an index of attentional switching between social and non-social information.
|
During the full 27-second video presentation
|
|
Mean Distance of Fixation Points from the Center of the Face Area of Interest
Tidsramme: During the full 27-second video presentation
|
For each fixation, the Euclidean distance (in degrees of visual angle) from its location to the centroid of the pre-defined face AOI was calculated.
The mean of these distances across all fixations was then computed.
Larger values indicate that gaze tended to fall farther from the faces, reflecting less attention to facial information.
|
During the full 27-second video presentation
|
Samarbeidspartnere og etterforskere
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- UESTC-GazeLab-02
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .